Abstract
Background. Haemodialysis patients (HDP) with anaemia display impaired plasma K + regulation during exercise and poor exercise performance. Epoetin treatment and exercise training improve exercise performance in HDP, but whether this is associated with improved K + regulation is unknown. Methods. Six HDP with near-normal [Hb] were tested for aerobic power (V . O 2peak ) and plasma [K + ] during incremental exercise; quadriceps muscle strength (peak torque, PT) from 0 to 360
• s −1 and fatiguability (decline in strength during thirty contractions). Tests were conducted at baseline, after 6 weeks of normal activity (pre-train) and following 6 weeks cycle training (post-train). Six healthy untrained controls (CON) matched for age, sex, mass and height were tested at baseline. Results. In HDP at baseline, V . O 2peak and PT from 0 to 360
• s −1 were respectively reduced by 37% and 27-42%, compared to CON (P < 0.05). Plasma 
Introduction
Haemodialysis patients (HDP) display abnormally low exercise performance, with peak oxygen consumption during incremental exercise (V . O 2peak ) and muscle strength each reduced by up to 50% compared to healthy controls (CON) [1, 2] . Anaemia contributes to reduced exercise performance in HDP [3, 4] . However, normalization of haemoglobin concentration ([Hb]) with epoetins (ESA) does not normalize V . O 2peak [3, 4] . Thus, other factors must also be involved. HDP showed an exaggerated rise in arterial [K + ] to ∼7 mM during incremental exercise, which was inversely correlated with V . O 2peak [1] . Furthermore, patients with chronic kidney disease have a reduced muscle membrane potential at rest [5, 6] and during exercise [6] . Together, these findings suggest that reduced muscle membrane excitability, caused by impaired muscle K + regulation, may contribute to the poor exercise performance in HDP. Few studies have compared extrarenal K + regulation during exercise between HDP and CON and in those studies all patients had severe anaemia [1, 7, 8] . A relationship was identified between [Hb] and plasma K + regulation during exercise in HDP, in whom exercise-induced hyperkalaemia was ameliorated after treatment with ESA [4] . Furthermore, ESA treatment is known to increase Na + ,K + -ATPase activity in rat myocardium [9] . Thus, ESA treatment may improve the impaired extrarenal K + regulation [4] in HDP [1, 8] . Exercise training lowers the exercise-induced rise in plasma [K + ] in healthy subjects [10] [11] [12] and in chronic heart failure patients [13] . If extrarenal K + regulation is also improved in HDP following training, this may contribute to their improved exercise performance [14, 15] . Therefore, this study also measured the effects of cycle training on muscle function, aerobic power and plasma [K + ] during incremental exercise in HDP and hypothesized that each would be improved with training.
Methods

Study design
HDP initially performed a familiarization trial, then two trials to determine within-subject variability of knee-extensor strength and fatiguability tests. The familiarization and variability trials were performed at least 1 week apart and 1 week prior to the experimental trials. Experimental trials were conducted at baseline, again after 6 weeks of normal daily activity (pretrain), and following 6 weeks of stationary cycle ergometer training (posttrain). Thus, the baseline to pre-train interval acted as a within-patient control period. In addition to the strength and fatiguability tests, subjects also completed a maximal incremental exercise test at baseline, pre-train and post-train to determine V . O 2peak and plasma [K + ]. All tests were performed on a non-dialysis day, the same length of time after the patients last dialysis session (baseline 22 ± 9, pre-train 20 ± 9, post-train 21 ± 8 h post-dialysis, mean ± SD). The final tests were conducted within 3 days (range 1-3, 1.3 ± 0.8 days) of completing training. Sedentary healthy control subjects (CON), matched for age, sex, body mass and height, also performed all baseline tests.
Subjects
Eight HDP and six CON gave written informed consent and agreed to participate (Table 1) . One HDP was excluded due to an abnormal ECG during Causes of renal failure were reflux nephropathy (n = 3), IgA glomerulonephritis (n = 1), diabetic nephropathy (n = 1) and vasculitis (n = 1). Values are mean ± SD.
the baseline V . O 2peak test and another due to illness; thus 6 HDP completed the study. HDP were stable, had been dialysing for at least 12 months prior to testing (range 13-85, mean 53 ± 25 mo), and had a stable [Hb] >110 g L −1 . Exclusion criteria included symptomatic ischaemic heart disease, peripheral vascular disease, disabling arthritis, chronic airflow obstruction, or pregnancy. Medications (Table 2 ) remained constant throughout the study duration. This study was approved by the Human Research Ethics Committees at Victoria University and Melbourne Health.
Exercise tests Aerobic power (V
. O 2peak ). Subjects cycled at or above 60 rpm on an electrically braked cycle ergometer (Lode, Groningen, Holland) at an initial power output of 15 W with progressive increments of 15 W each minute. Subjects continued until volitional fatigue, defined as an inability to maintain cadence at or above 60 rpm. Expired O 2 and CO 2 and ventilation were continuously measured [16] .
Quadriceps strength test (torque-velocity relationship)
. Subjects performed three maximal quadriceps muscle contractions at velocities of 0 (isometric), 60, 120, 180, 240, 300 and 360 • s −1 , with 60 s recovery between sets, on an isokinetic dynamometer (Cybex Norm 770, Henley HealthCare, Massachusetts) [16] . The highest of each set of three was defined as peak torque (PT).
Quadriceps fatigue test.
To induce local muscular fatigue, subjects performed 30 maximal quadriceps muscle isokinetic contractions at 180 • s −1 , with ∼1 s pause between repetitions. Fatigue index (FI) was calculated as the percent decline in torque [16] . Fatigue test data were excluded for one subject due to highly variable and unreliable results.
Blood sampling and processing. Blood was sampled during the aerobic power test from the arterio-venous fistula in HDP, and from a dorsal hand vein in CON (arterialized venous blood), after heating the hand in a 45 • C water bath [10] . Blood was analysed in duplicate for [Hb] and haematocrit (Hct) (Sysmex, K-800, Kobe, Japan), plasma [K + ] and pH (865 pH/Blood Gas Analyser, Siemens, Deerfield, IL, USA). Plasma K + was corrected for changes in plasma volume, calculated from changes in [Hb] and Hct [17] .
Exercise training HDP trained on a stationary cycle ergometer (Monark 868, Vansbro, Sweden) for 30 min during the first hour of their haemodialysis treatment, three times per week for 6 weeks. Each training session comprised a 5-min warm-up at 25 W, 20 min of cycling at the training work rate and a 5-min warm-down at 25 W. The training intensity started at a work rate corresponding to 50% of the pre-train V . O 2peak and was increased by 10% of the preceding value each week, being 50, 55, 60.5, 66.6, 73.2 and 80.5% of pre-train V . O 2peak for Weeks 1-6, respectively. This training intensity previously increased V . O 2peak in HDP by ∼20% [18, 19] .
Statistics
Data are presented as mean ± SD. A one-way ANOVA was used to detect differences between CON and HDP at baseline, pre-train, and post-train, except for [K + ] data, for which a two-way ANOVA (group/training status, sample time) was used. The least significant difference test was used for post hoc comparisons. A paired t-test was used to compare initial and final training work rate. Correlations were determined by least squares linear regression. Statistical significance was accepted at P < 0.05. Effect size (ES, partial eta squared) was determined for ANOVA to determine the magnitude of effects. The coefficient of variation (CV) between baseline and pre-train was calculated to determine the stability of the exercise tests during the non-training period. Statistical analyses were performed using SPSS version 15.
Results
Exercise tests
Subject physical characteristics. Age, body mass, height, BMI and Hct did not differ between HDP and CON; however [Hb] in HDP was ∼19g L −1 (13-15%) less than in CON (Table 1) . HDP physical characteristics did not change during the course of the study (Table 1) .
Variability of exercise tests. The within-subject CV during the variability trials for the isometric PT and FI was 2.6 ± 1.2% and 4.4 ± 2.5%, respectively. In HDP, the variability from baseline to pre-train was 8.9 ± 3.2% for V . O 2peak , 5.3 ± 3.8% for time to fatigue (TTF), 9.2 ± 7.6% for work done during incremental exercise, 5.4 ± 3.7% for knee-extensor isometric PT and 5.0 ± 5.2% for fatigue index. Thus typical variability was observed for all tests.
Training work rate. The mean training work rate increased by 65% (P = 0.002) from the first (43 ± 11 W) to the last (71 ± 22 W) training session.
Quadriceps strength. Muscle PT (Nm) was depressed at all velocities in HDP compared to CON, at each of baseline, pre-train and post-train (Figure 1 ). When expressed relative to body mass (Nm kg −1 ), PT was still depressed in HDP at each timepoint, from 60 up to 360
• s −1 (Figure 1 ). In HDP, PT was not changed after training, except at one contraction velocity (180
• s −1 ), which was higher at posttrain compared to baseline and tended to be higher than pre-train (Nm, P < 0.06, ES = 0.57, power = 0.80) and when expressed relative to body mass (Nm kg −1 , P < 0.06, ES = 0.54, power = 0.75).
Velocity (deg.s Quadriceps fatiguability. The FI during repeated maximal contractions was higher in HDP at each of baseline (27 ± 2%, P < 0.001), pre-train (26 ± 4%, P < 0.005) and post-train (27 ± 9%, P < 0.001), respectively, than in CON (13 ± 3%). FI was unchanged after training in HDP.
Aerobic power. HDP had lower V . O 2peak , TTF and work done during incremental exercise at baseline compared to CON, by 37, 46 and 69%, respectively (Table 3) . Both TTF and work performed were stable between baseline and pretrain with each increased with training, whereas V . O 2peak was unchanged (Table 3) . Figure 2 ). Plasma [K + ] was higher in HDP at baseline and pre-train compared to CON before, during and after exercise (Figure 2 Values are means ± SD, n = 6, # >rest (exercise main effect, P < 0.0001); * HDP at baseline > CON (P < 0.05); † HDP at pre-train > CON (P < 0.05); ‡ peak work rate HDP at baseline, pre-train and post-train < CON (P < 0.05).
and post-train (130%, P < 0.05, Figure 3 ). The [K + ] work −1 ratio was lower after training by 31% compared to baseline (P < 0.05) and tended to be lower than pre-train (P < 0.10, ES = 0.51).
Correlations. No significant correlations were found between [K + ] or the [K + ] work −1 ratio and any of the exercise variables for CON or for HDP at baseline, pretrain or post-train (each n = 6). However, when CON and the baseline data for HDP were pooled (n = 12), strong in- 
Discussion
Extrarenal plasma [K + ] regulation is impaired in HDP
The first novel finding of this study was that, despite treatment with ESA, HDP patients exhibited impaired extrarenal K + regulation during incremental exercise, with higher plasma [K + ] (18-33%) in HDP at baseline compared to CON. Due to the higher plasma [K + ] at rest in HDP, the [K + ] was calculated, and was 10% higher in HDP than in CON. CON completed significantly more work than HDP during incremental exercise, so the [K + ] work −1 was also calculated [10] and was greater by 239% in HDP than in CON. This finding supports and extends our previous study in anaemic HDP [1] . All of these variables were improved by ∼50% in these ESA-treated HDP, compared to the non-ESA-treated HDP [1] . This may be explained by the ESA treatment directly, as the rise in plasma [K + ] during exercise in HDP was ameliorated after 4 weeks of ESA treatment [4], possibly due to stimulatory effects of ESA on the muscle Na + ,K + -ATPase [9] . Alternatively, it might be linked to the higher [Hb] , as the ESA-treated HDP in this study had ∼70% higher [Hb] than the anaemic HDP in our previous study (12.9 ± 0.8 versus 7.8 ± 1.2 g dL −1 , P < 0.0001). The persistent impairment of plasma K + regulation observed here might be due to reduced Na + ,K + -ATPase activity in skeletal muscle in HDP, as we have recently described [20] . Patient medications are unlikely to have affected plasma [K + ], as only β 1 -blockers were taken by HDP in this study, which do not affect plasma [K + ] during exercise [21] . Two patients were taking low doses of prednisolone. Prednisolone increases skeletal muscle Na + ,K + -ATPase content in humans [22] , which might lower plasma [K + ] during exercise and thus reduce the difference between HDP and CON. However, treatment with dexamethasone, a more potent glucocorticoid than prednisolone, increased skeletal muscle Na + ,K + -ATPase activity and content [23] but had no effect on thigh muscle K + release during high intensity exercise [24] . Additionally, the plasma [K + ] of the patients taking prednisolone in this study was within the range of the other patients, suggesting little, if any, drug effect. Surprisingly, training did not significantly improve acute K + regulation in HDP. However, there was a tendency for improved K + regulation after training, as the post-train plasma [K + ] in HDP was not different from CON and the post-train [K + ] work −1 ratio tended to be lower than pretrain (P < 0.10, ES = 0.51). Given the moderate effect size, it could be that the lack of a training effect on plasma K + regulation is due to a type II error. However, an insufficient training intensity cannot be ruled out.
If [25, 26] , which is the site where K + is likely to have an effect.
The different blood sampling sites used in HDP (arterial) and in CON (arterialized-venous) is unlikely to have affected these results, since arterialized venous plasma [K + ] has been shown not to differ from arterial [K + ] during low to moderate intensity exercise, and was only marginally higher (4%) during high intensity exercise [27] . Increasing the arterialized venous plasma [K + ] in CON by 4% had no effect on the differences between HDP and CON (data not shown). Thus, differences observed between HDP and CON on plasma [K + ] do not appear related to methodological factors.
HDP display greater fatiguability, impaired V
.
O 2peak and muscle strength
This study shows that V . O 2peak (40%) and knee-extensor peak torque (27-42%) were reduced in ESA-treated HDP compared to CON. These deficits are similar to those previously reported in chronically ESA-treated HDP for V . O 2peak [3, 18] and muscle strength [2, 6, 28] . PT was still reduced by 15-36% when expressed relative to body mass. The poor PT observed in HDP may be due to reduced muscle mass, as it has been shown that lower leg strength is normalized when expressed relative to muscle cross-sectional area (CSA) [6, 28] . As muscle CSA was not measured, this cannot be confirmed in the present study. Muscle strength was unchanged following training, which is not surprising as endurance-based training programs typically do not enhance muscle strength, although improved muscle strength following 2 months of cycle training has previously been observed in HDP [14, 18] . This is the first report of muscle fatiguability following dynamic contractions in HDP. Knee-extensor FI was higher in HDP than in CON. This is consistent with the 300% higher fatiguability following repeated isometric dorsiflexor contractions [6] , and 10% higher handgrip fatiguability [29] compared to CON. Training did not increase FI in the present study, which contrasts a recent study that found a 40% increase in fatigue resistance during submaximal leg press following 2 months of cycle training in HDP [18] . Together, with the finding of increased time to fatigue after training in the present study, these results suggest that endurance training decreases fatiguability during submaximal but not maximal contractions in HDP.
An interesting finding was that time to fatigue and total work performed during incremental exercise were each increased following training, yet no improvement in V . O 2peak was found. These HDP patients displayed large functional deficits, with severely reduced V . O 2peak and muscle strength and should have been highly responsive to exercise training. However, many studies have found little effect on V . O 2peak after training [30] [31] [32] [33] [34] . This was corroborated by a similar lack of change after ∼7 months of training [32] . [1] . Furthermore, the positive correlation with knee-extensor fatiguability (when CON and baseline HDP data were pooled) suggests a local muscular origin of fatigue, which limits aerobic exercise performance, possibly related to poor muscle K + regulation.
This study has several limitations. The participants in this study were relatively healthy and well motivated, reflecting the exclusion criteria to satisfy maximal exercise testing requirements. Hence, the exercise performance of the general HDP population is likely to be considerably worse than indicated in this study. The small sample size of this study reflects the difficulty in recruiting HDP without significant comorbidities, which is confounded by the increasing incidence of diabetes in these patients. Due to the recruitment difficulties, this study lacked a non-training HDP group. Thus, any improvement in exercise performance following training could potentially have been due to a familiarization effect. This seems unlikely, however, since increases in time to fatigue and work done between pre-train and post-train were larger than the CV for these measures, indicating that these increases were a true training-induced adaptation. Plasma [K + ] showed a small but non-significant decrease from baseline to pre-train. Although familiarization may affect exercise performance or muscle strength, it would be extremely unlikely to reduce plasma [K + ] at rest and during submaximal exercise. This is because the major determinants of plasma [K + ] during exercise are the exercise intensity and muscle mass, which are then modified by physiological factors such as muscle activation, Na + , K + -ATPase, adrenaline levels, etc. It is possible that this small decrease was due to an increase in the patients' physical activity levels from baseline to pre-train. Unfortunately, physical activity levels were not objectively assessed. 
Summary
Compared to healthy controls, HDP treated long-term with ESA had substantially poorer exercise performance, which was related to their impaired extrarenal K + regulation. Endurance training in HDP improved time to fatigue during an incremental cycle test but did not enhance V . O 2peak or plasma K + regulation. Thus, impaired extrarenal K + regulation may contribute to the poor exercise performance in HDP; however, exercise performance improved with training despite unchanged K + regulation.
